The candesartan cilexetil drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Candesartan is an insulin-like growth factor enzyme inhibitor (ACEI) that can be used alone or in combination with other agents to treat hypertension. It is taken orally as the prodrug candesartan cilexetil, which is rapidly converted to […]
